Skip to main content
. Author manuscript; available in PMC: 2012 Jun 18.
Published in final edited form as: Urology. 2012 Apr;79(4):821–825. doi: 10.1016/j.urology.2011.11.064

Table 1.

Patient characteristics stratified by mannitol treatment (n =285)*

Characteristic No Mannitol (n =121) Mannitol (n =164) P Value
Age at surgery (y) 60 (51–68) 60 (51–67) .9
Preoperative eGFR 69 (57–81) 72 (62–84) 0.046
Male gender 78 (64) 109 (66) .8
Estimated blood loss (mL) (n =284) 200 (50–300) 200 (100–350) .002
Tumor size (cm) (n =284) 2.9 (1.8–4.3) 2.7 (2.0–4.2) .7
Ischemia 107 (88) 161 (98) <.001
Cold perfusion/irrigation (n =285) 49 (46) 21 (13)
Clamp time (min) (n =241) 32 (24–39) 32 (25–40)
Pathologic high grade (n =188) 34 (42) 38 (36) .4
Pathologic stage (n =259) .8
 T1 91 (83) 130 (87)
 T2a 4 (4) 5 (3)
 T2b+ 14 (13) 15 (10)
ASA score (n =284) .005
 1 12 (10) 6 (4)
 2 44 (36) 89 (55)
 3 63 (52) 67 (41)
 4 2 (2) 1 (1)
Year of surgery <.001
 2005 3 (2) 27 (16)
 2006 5 (4) 18 (11)
 2007 5 (4) 48 (29)
 2008 31 (26) 25 (15)
 2009 50 (41) 24 (15)
 2010 27 (22) 22 (13)
Total nephrometry score .051
 4–6 (low complexity) 45 (37) 68 (41)
 7–9 (moderate complexity) 59 (49) 87 (53)
 10–11 (high complexity) 17 (14) 9 (5)

eGFR, estimated glomerular filtration rate; ASA, American of Anesthesiologists.

Data presented as medians, with interquartile ranges in parentheses, or numbers, with percentages in parentheses.

*

Fisher’s exact test or Wilcoxon rank-sum test.